UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Zevra Therapeutics Inc (ZVRA)

Zevra Therapeutics Inc (ZVRA)
8.01 x 4 8.51 x 45
Post-market by (Cboe BZX)
8.01 unch (unch) 03/21/25 [NASDAQ]
8.01 x 4 8.51 x 45
Post-market 8.01 unch (unch) 16:22 ET
Quote Overview for Fri, Mar 21st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
7.87
Day High
8.14
Open 7.91
Previous Close 8.01 8.01
Volume 1,686,800 1,686,800
Avg Vol 529,870 529,870
Stochastic %K 60.94% 60.94%
Weighted Alpha +23.56 +23.56
5-Day Change -0.30 (-3.61%) -0.30 (-3.61%)
52-Week Range 4.20 - 9.76 4.20 - 9.76
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 433,469
  • Shares Outstanding, K 54,116
  • Annual Sales, $ 23,610 K
  • Annual Income, $ -105,510 K
  • EBIT $ -81 M
  • EBITDA $ -75 M
  • 60-Month Beta 1.98
  • Price/Sales 18.36
  • Price/Cash Flow N/A
  • Price/Book 10.78

Options Overview Details

View History
  • Implied Volatility 83.49% ( -43.24%)
  • Historical Volatility 46.52%
  • IV Percentile 34%
  • IV Rank 23.23%
  • IV High 258.40% on 07/30/24
  • IV Low 30.57% on 06/06/24
  • Put/Call Vol Ratio 0.12
  • Today's Volume 169
  • Volume Avg (30-Day) 217
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 16,440
  • Open Int (30-Day) 15,323

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.21
  • Number of Estimates 3
  • High Estimate -0.17
  • Low Estimate -0.24
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +47.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.21 +11.10%
on 03/04/25
Period Open: 7.68
8.49 -5.65%
on 03/14/25
+0.33 (+4.30%)
since 02/21/25
3-Month
7.21 +11.10%
on 03/04/25
Period Open: 8.49
8.95 -10.50%
on 01/03/25
-0.48 (-5.65%)
since 12/20/24
52-Week
4.20 +90.71%
on 07/05/24
Period Open: 5.84
9.76 -17.93%
on 11/25/24
+2.17 (+37.16%)
since 03/21/24

Most Recent Stories

More News
Zevra Therapeutics: Q4 Earnings Snapshot

Zevra Therapeutics: Q4 Earnings Snapshot

ZVRA : 8.01 (unch)
Zevra Reports Full Year 2024 and Fourth Quarter Financial Results

ZVRA : 8.01 (unch)
Zevra Launches New Disease State Awareness Campaign, ‘Learn NPC, Read Between the Signs,’ to Drive Early Recognition and Treatment of Niemann-Pick Disease Type C

ZVRA : 8.01 (unch)
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million

ZVRA : 8.01 (unch)
Zevra to Report 2024 Fourth Quarter and Full Year Financial Results

ZVRA : 8.01 (unch)
Zevra to Participate at Upcoming Investor Conferences

ZVRA : 8.01 (unch)
2 ‘Strong Buy’ Growth Stocks Poised for 141% to 193% Gains, According to Wall Street

The recent advancements in their pipelines imply high growth potential in the coming years.

ZVRA : 8.01 (unch)
RPRX : 33.70 (+0.60%)
SNDX : 13.71 (-2.77%)
INCY : 61.92 (+2.21%)
Zevra Therapeutics to Present at the 21st Annual WORLDSymposiumâ„¢

ZVRA : 8.01 (unch)
Zevra Therapeutics to Participate at Upcoming Investor Conferences

ZVRA : 8.01 (unch)
Zevra Therapeutics, Inc. to be Added to Nasdaq Biotechnology Index Effective December 23, 2024

Zevra Therapeutics to join the Nasdaq Biotechnology Index effective December 23, enhancing its visibility in the biotech sector.Quiver AI SummaryZevra Therapeutics, Inc. announced that it will be added...

ZVRA : 8.01 (unch)

Business Summary

Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. Zevra Therapeutics, formerly known as KemPharm Inc., is based in CELEBRATION, Fla.

See More

Key Turning Points

3rd Resistance Point 8.42
2nd Resistance Point 8.28
1st Resistance Point 8.15
Last Price 8.01
1st Support Level 7.87
2nd Support Level 7.73
3rd Support Level 7.59

See More

52-Week High 9.76
Last Price 8.01
Fibonacci 61.8% 7.64
Fibonacci 50% 6.98
Fibonacci 38.2% 6.32
52-Week Low 4.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals